109 - 110年度市售中藥材異常物質之品質監測   全文下載

Surveillance of Abnormal Substances in Chinese Herbs between 2020 and 2021

本調查於109 - 110年間由各地方政府衛生局至轄區內抽查市售中藥材三七等57品項共616件中藥材檢體進行異常物質檢驗，檢驗項目包含二氧化硫與分項重金屬（鉛、鎘、汞、砷），據以了解該等產品之安全性以確保民眾用藥安全。異常物質檢驗結果顯示11件中藥材不符合規定，其中7件二氧化硫超出限量基準，4件重金屬超出限量基準，不合格率為1.8%。本調查之檢驗結果均已通知原送地方政府衛生局及衛生福利部中醫藥司，進行相關行政處辦，以確保國人用藥安全，展現政府把關國人藥食安全之決心。

In order to ensure the quality of Chinese herbs, 616 samples (including 57 items of Chinese herbs) were collected and analyzed for sulfur dioxide and heavy metals (lead, cadmium, mercury and arsenic) between 2020 and 2021. The results were determined according to the regulations annouced by the Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare (MOHW). The inspection results of abnormal substances showed that 11 simples of Chinese herbal medicines did not meet the regulations, 7 of which exceeded the limit for sulfur dioxide and 4 for heavy metals, with a noncompliance rate of 1.8%. The investigation results have been notified to related authorities including local health bureaus and Department of Chinese Medicine and Pharmacy, MOHW to protect public health and medication safety.